• HyperPFU™ High-Fidelity DNA Polymerase: Practical PCR Guidan

  2026-06-23

  HyperPFU™ high-fidelity DNA polymerase enables accurate PCR amplification of long, GC-rich, or otherwise challenging DNA templates by providing exceptional fidelity and robust performance where standard polymerases often fail. It is best suited for workflows needing blunt-ended, high-fidelity PCR products for cloning and sequencing, but should not be used where 3'-A overhangs or sticky ends are required.

• CTOP: Precision μ-Opioid Receptor Antagonist for Mechanistic

  2026-06-22

  CTOP empowers researchers to dissect central opioid signaling with unmatched selectivity, enabling robust investigation of mechanical hypersensitivity and analgesic tolerance. This article delivers actionable workflows, troubleshooting strategies, and protocol insights to maximize CTOP's impact in advanced neuropharmacology and pain mechanism research.

• Capsazepine: TRPV1 Ion Channel Antagonist for Pain Research

  2026-06-22

  Capsazepine is a synthetic TRPV1 ion channel antagonist with high selectivity and robust potency. It is widely used to dissect nociception mechanisms and apoptosis sensitization in colon cancer cells. Quantitative benchmarks establish its role as a reference inhibitor for TRPV1- and TRPM8-mediated pain pathways.

• Chronic Cathepsin Inhibition by E-64 in Salt-Sensitive Hyper

  2026-06-21

  This study rigorously examines the effects of chronic cysteine protease inhibition using E-64, a potent L-trans-epoxysuccinyl peptide inhibitor, in a Dahl salt-sensitive rat model of hypertension. The findings challenge expectations by demonstrating that sustained cathepsin inhibition did not alter the progression of hypertension or kidney damage under high-salt conditions, informing future research into the mechanistic roles of cysteine cathepsins in cardiovascular and renal pathology.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-20

  This study provides clear evidence that male and female mice differ significantly in their cardiovascular responses to chronic angiotensin II infusion, with males showing a greater increase in blood pressure. The research advances mechanistic understanding of sex hormone modulation in autonomic regulation and offers a foundation for future hypertension and neuronal signaling pathway research.

• Reactive Oxygen Species Assay Kit: Precision in Live-Cell RO

  2026-06-19

  The Reactive Oxygen Species Assay Kit enables quantitative, live-cell measurement of oxidative stress using the DCFH-DA fluorescent probe. Its validated workflow and reagents provide robust, reproducible data for studies in cell signaling, apoptosis, and disease pathophysiology.

• Ruthenium Red: Precision Ca2+ Transport Inhibition in Autoph

  2026-06-19

  Ruthenium Red, a high-affinity Ca2+ transport inhibitor, enables reproducible dissection of cytoskeleton-dependent autophagy and mechanotransduction. This guide details evidence-based workflows, troubleshooting, and the unique experimental advantages of using APExBIO's Ruthenium Red in advanced calcium signaling research.

• Optimizing Assay Consistency with DIDS (4,4'-Diisothiocyanos

  2026-06-18

  This article provides an evidence-driven, scenario-based guide for leveraging DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) (SKU B7675) in cell viability, proliferation, and cytotoxicity workflows. We highlight how SKU B7675 delivers robust chloride channel inhibition, reproducible protocol performance, and practical improvements in experimental design. Bench scientists will find actionable insights for assay reliability and data interpretation.

• Capsaicin: Dual TRPV1 Activation and KDM1A Inhibition in Res

  2026-06-18

  Capsaicin, a vanillamide compound, is a validated activator of TRPV1 ion channels and a potent, reversible inhibitor of KDM1A. Its dual mechanism supports applications in pain, inflammation, and gastric cancer models. APExBIO provides a rigorously characterized Capsaicin (SKU C6366) for reproducible research.

• Capsazepine in Translational Pain Research: Mechanisms, Mode

  2026-06-17

  Explore how Capsazepine, a synthetic TRPV1 ion channel antagonist, bridges mechanistic insight and experimental rigor to unlock next-generation pain research and apoptosis studies. Drawing on recent evidence and translational paradigms, this article guides researchers in leveraging Capsazepine for innovative preclinical models, competitive differentiation, and clinical relevance—while critically assessing opportunities and limitations.

• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research

  2026-06-17

  Capsazepine, a synthetic TRPV1 ion channel antagonist, empowers researchers to dissect nociceptive and apoptotic pathways with precision. This guide offers actionable workflows, troubleshooting strategies, and evidence-based tips for maximizing its utility in pain and cancer research models.

• GLP-1 (9-36) amide: Optimizing GLP-1R Antagonism in Metaboli

  2026-06-16

  GLP-1 (9-36) amide empowers researchers to dissect GLP-1 receptor signaling with precision, enabling advanced metabolic and type 2 diabetes models. This guide translates bench-level workflows, troubleshooting, and assay innovation for maximum reproducibility and insight.

• Capsaicin ((E)-Capsaicin): Optimizing TRPV1 & KDM1A Assays

  2026-06-16

  Capsaicin ((E)-Capsaicin) uniquely enables dual interrogation of TRPV1 ion channel activation and KDM1A/LSD1 inhibition in translational models of pain, inflammation, and cancer. This guide delivers protocol-ready workflow enhancements, troubleshooting tips, and evidence-mapped insights to maximize experimental reproducibility and assay precision with APExBIO's validated Capsaicin.

• Topological Stress Induces Persistent rDNA Damage via PML-Nu

  2026-06-15

  This study reveals that topological stress and RNA polymerase I inhibition induce persistent DNA lesions in ribosomal DNA, leading to the formation of PML-nucleolar associations (PNAs). The findings clarify how these nuclear structures are triggered by specific DNA damage and repair pathway engagement, deepening our understanding of genome stability and cellular senescence.

• SAF312 as a Potent TRPV1 Antagonist for Ocular Surface Pain

  2026-06-15

  The reference study introduces SAF312 (Libvatrep) as a selective and potent TRPV1 antagonist, addressing a significant gap in ocular surface pain management. Through rigorous preclinical pharmacology and toxicology assessments, SAF312 demonstrates high TRPV1 selectivity, safety, and no impairment of corneal wound healing, supporting its potential for clinical development.

14722 records 1/982 page Next 12345 下5页 Last page